title: Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells.
abstract: In cultured vascular smooth muscle cells (SMCs), STAT3 mediates proliferation signal by directly activating transcription of early growth response genes. Recently, we have found that balloon injury transiently induces JAK2 and STAT3 expressions and activations with a peak at day 7 in rat carotid artery. However, the specific role of STAT3 in neointima formation remains unknown. Adenoviral vector encoding a dominant negative STAT3 (AxCAdnSTAT3) or beta-galactosidase (control) was overexpressed in a balloon-injured artery to inhibit endogenous STAT3 activation selectively. In controls, neointima became evident after day 4, and reached a maximum at day 14. The number of bromodeoxyuridine (BrdU)-positive proliferating or TUNEL-positive apoptotic neointimal SMCs peaked at day 7, decreasing to lower levels by day 14. AxCAdnSTAT3 not only abrogated STAT3 phosphorylation but also decreased BrdU labeling index by 60% and increased TUNEL index by 35% at day 7 versus controls, resulting in the 40% reduction in the intima/media area ratio at day 14. At day 7, in controls, vascular injury upregulated antiapoptotic mediator Mcl-i and Bcl-xL expression by 8-fold to 5-fold, respectively, versus sham, whereas proapoptotic Bax slightly increased by 1.5-fold versus sham. AxCAdnSTAT3 reversed the upregulated Mcl-1 and Bcl-xL levels by 70% and 37%,respectively, while having no affect on Bax expression. In conclusion, the STAT3-mediated pathway plays an important role in neointima formation through enhanced vascular SMC accumulation by promoting cell proliferation and survival.
authors.affiliation: Cardiovascular Research Institute and The Third Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan.
authors.forename: Rei
authors.initials: R
authors.lastname: Shibata
authors.forename: Hisashi
authors.initials: H
authors.lastname: Kai
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Seki
authors.forename: Seiya
authors.initials: S
authors.lastname: Kato
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Wada
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Hanakawa
authors.forename: Koji
authors.initials: K
authors.lastname: Hashimoto
authors.forename: Akihiko
authors.initials: A
authors.lastname: Yoshimura
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Imaizumi
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000800:Angioplasty, Balloon; D000818:Animals; D017209:Apoptosis; D001157:Arterial Occlusive Diseases / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D002454:Cell Differentiation; D002455:Cell Division; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D003673:Defective Viruses / Q000235:genetics; D005822:Genetic Vectors; D007150:Immunohistochemistry; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000473:pathology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D050796:STAT3 Transcription Factor; D015534:Trans-Activators / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D017539:Tunica Intima / Q000276:immunology / Q000473:pathology / Q000648:ultrastructure; D001616:beta-Galactosidase / Q000235:genetics / Q000378:metabolism
chemical_list: D004268:DNA-Binding Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D050796:STAT3 Transcription Factor; C494088:Stat3 protein, rat; D015534:Trans-Activators; D001616:beta-Galactosidase